Additional file 1 of Olfaction and substantia nigra echogenicity in young individuals with 22q11.2 deletion syndrome, a population at high risk for dopaminergic neuropsychiatric disease

Le résumé fourni par la source

Supplementary Material 1. Supplementary Table1 Non-parametric testing regarding correlations of size of the echogenic area of the substantia nigra (SN_max_mean) and symptom scores of the Movement Disorder Society (MDS)-sponsored new version of the Unified Parkinson’s Disease Rating Scale (UPDRS) in the total sample. A negative correlation between SNmax and MDS-UPDRS score was retained while in the 22q11.2DS subgroup (not shown) there was no significant correlation.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.